Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Tax Rate (2021 - 2026)

Barinthus Biotherapeutics (BRNS) has disclosed Tax Rate for 6 consecutive years, with 0.29% as the latest value for Q1 2026.

  • For Q1 2026, Tax Rate rose 18.0% year-over-year to 0.29%; the TTM value through Mar 2026 reached 0.32%, up 28.0%, while the annual FY2025 figure was 0.26%, 19.0% up from the prior year.
  • Tax Rate hit 0.29% in Q1 2026 for Barinthus Biotherapeutics, down from 0.51% in the prior quarter.
  • Across five years, Tax Rate topped out at 8.71% in Q4 2022 and bottomed at 50.44% in Q1 2022.
  • Average Tax Rate over 5 years is 2.3%, with a median of 0.24% recorded in 2024.
  • Year-over-year, Tax Rate plummeted -5118bps in 2022 and then soared 5319bps in 2023.
  • Barinthus Biotherapeutics' Tax Rate stood at 8.71% in 2022, then tumbled by -48bps to 4.53% in 2023, then crashed by -100bps to 0.01% in 2024, then skyrocketed by 3605bps to 0.51% in 2025, then tumbled by -44bps to 0.29% in 2026.
  • According to Business Quant data, Tax Rate over the past three periods came in at 0.29%, 0.51%, and 0.48% for Q1 2026, Q4 2025, and Q3 2025 respectively.